227 related articles for article (PubMed ID: 20580665)
1. Reproductive Toxicology. Editorial.
Piersma AH
Reprod Toxicol; 2010 Aug; 30(1):1. PubMed ID: 20580665
[No Abstract] [Full Text] [Related]
2. Evidence-Based Toxicology Collaboration (EBTC). Editorial.
von Aulock S
ALTEX; 2013; 30(1):1. PubMed ID: 23451363
[No Abstract] [Full Text] [Related]
3. Gender-based differences in endocrine and reproductive toxicity.
Cummings AM; Stoker T; Kavlock RJ
Environ Res; 2007 May; 104(1):96-107. PubMed ID: 17157289
[TBL] [Abstract][Full Text] [Related]
4. The integrated project ReProTect: a novel approach in reproductive toxicity hazard assessment.
Hareng L; Pellizzer C; Bremer S; Schwarz M; Hartung T
Reprod Toxicol; 2005; 20(3):441-52. PubMed ID: 15899576
[TBL] [Abstract][Full Text] [Related]
5. Implications of gender differences for human health risk assessment and toxicology.
Vahter M; Gochfeld M; Casati B; Thiruchelvam M; Falk-Filippson A; Kavlock R; Marafante E; Cory-Slechta D
Environ Res; 2007 May; 104(1):70-84. PubMed ID: 17098226
[TBL] [Abstract][Full Text] [Related]
6. Toxicology testing steps towards computers.
Kling J
Lab Anim (NY); 2019 Feb; 48(2):40-42. PubMed ID: 30643278
[No Abstract] [Full Text] [Related]
7. Uncertainty factors in noncancer risk assessment.
Dourson M
Regul Toxicol Pharmacol; 1996 Oct; 24(2 Pt 1):107. PubMed ID: 8933623
[No Abstract] [Full Text] [Related]
8. Novel strategies for toxicological risk assessments.
Roy A; Akbarsha MA
ALTEX; 2014; 31(1):91-3. PubMed ID: 24448760
[No Abstract] [Full Text] [Related]
9. REACH testing requirements must not be driven by reproductive toxicity testing.
Spielmann H; Vogel R
Altern Lab Anim; 2006 Aug; 34(4):365-6. PubMed ID: 16945004
[No Abstract] [Full Text] [Related]
10. Reproductive health hazards in the pharmaceutical industry.
Clement JD
Occup Med; 1997; 12(1):131-43. PubMed ID: 9153058
[TBL] [Abstract][Full Text] [Related]
11. Assessment of reproductive toxicity under REACH.
Aulmann W
Regul Toxicol Pharmacol; 2012 Jul; 63(2):286-90. PubMed ID: 22475931
[TBL] [Abstract][Full Text] [Related]
12. Special issue: SBiRM: invited papers from MPI Research summit/symposium: Current trends in developmental and reproductive toxicology --August 21-23, 2011. Preface.
Faqi AS
Syst Biol Reprod Med; 2012 Feb; 58(1):1-2. PubMed ID: 22239075
[No Abstract] [Full Text] [Related]
13. Toxicology rethinks its central belief.
Calabrese EJ; Baldwin LA
Nature; 2003 Feb; 421(6924):691-2. PubMed ID: 12610596
[No Abstract] [Full Text] [Related]
14. Utilization of animal studies to determine the effects and human risks of environmental toxicants (drugs, chemicals, and physical agents).
Brent RL
Pediatrics; 2004 Apr; 113(4 Suppl):984-95. PubMed ID: 15060191
[TBL] [Abstract][Full Text] [Related]
15. The use of the rat in developmental immunotoxicology studies.
Chapin RE
Hum Exp Toxicol; 2002; 21(9-10):521-3. PubMed ID: 12458910
[TBL] [Abstract][Full Text] [Related]
16. Fundamentals are still relevant in toxicology.
Eaton DL; Greenlee WF
Nature; 2002 May; 417(6885):117. PubMed ID: 12000934
[No Abstract] [Full Text] [Related]
17. The challenge of reproductive and developmental toxicology under REACH.
Scialli AR
Regul Toxicol Pharmacol; 2008 Jul; 51(2):244-50. PubMed ID: 18490093
[TBL] [Abstract][Full Text] [Related]
18. Animal testing and alternative approaches for the human health risk assessment under the proposed new European chemicals regulation.
Höfer T; Gerner I; Gundert-Remy U; Liebsch M; Schulte A; Spielmann H; Vogel R; Wettig K
Arch Toxicol; 2004 Oct; 78(10):549-64. PubMed ID: 15170526
[TBL] [Abstract][Full Text] [Related]
19. Introduction to special issue on developmental and reproductive toxicology in China.
Daston GP
Birth Defects Res B Dev Reprod Toxicol; 2010 Feb; 89(1):1. PubMed ID: 20166228
[No Abstract] [Full Text] [Related]
20. Alternatives to the use of animals in research, education and testing.
Macharia Theuri S; Ngonyo J; Wangari Kagai M
ALTEX; 2016; 33(2):183-5. PubMed ID: 27032089
[No Abstract] [Full Text] [Related]
[Next] [New Search]
